The European Patent Office (EPO) confirmed on 8 April 2003 its decision made in 1999 to revoke all the PharmaStem (formerly Biocyte) patent claims on collecting, freezing and using blood from foetuses and umbilical cords for transplants and medical and therapeutic treatments.
putting citizens' health at the heart of Europe
European Patent Office Confirms Revocation of Baby Blood Patent
Last modified on May 9 2003.
Your feedback is valuable to us!
Was this article interesting and relevant
for you? Do you have any comments?
You can post a reply to this article here.
Credits
The European Public Health Alliance runs projects which receive financial support from the European Commission. The views expressed in this website do not necessarily reflect the official views of the EU institutions.
This website is powered by open source solutions and runs on a Linux server.